Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Xenon Pharmaceuticals granted inducement equity awards to eight new non-officer employees under Nasdaq Listing Rule 5635(c)(4). The grants total 17,850 share options with a $38.93 exercise price and 10,500 RSUs, all effective October 1, 2026 under the Amended and Restated 2025 Inducement Equity Incentive Plan.
Key figures
- Rsu vesting
- 25% annually over four years
- Rsus granted
- 10500
- New employees
- 8
- Exercise price
- 38.93
- Option vesting
- 4 years, 25% at one-year anniversary then 1/36th monthly
- Share options granted
- 17850
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.